{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:54:51Z","timestamp":1773147291362,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/ctrv.2001.0233","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"295-304","source":"Crossref","is-referenced-by-count":61,"title":["BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling"],"prefix":"10.1053","volume":"27","author":[{"given":"M.O.","family":"Nicoletto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Donach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"De Nicolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Artioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Banna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Monfardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ctrv.2001.0233_RF1","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0959-8049(99)00246-4","article-title":"Screening for hereditary cancer and genetic testing, epitomised by breast cancer","volume":"35","author":"Eeles","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial sindrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1053\/ctrv.2001.0233_RF3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2168.2000.01347.x","article-title":"Genetic predisposition to breast cancer: a surgical perspective","volume":"87","author":"Sakorafas","year":"2000","journal-title":"Br J Surg"},{"key":"10.1053\/ctrv.2001.0233_RF4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-4608(00)00401-5","article-title":"Disruption of the ATM gene in breast cancer","volume":"126","author":"Lu","year":"2001","journal-title":"Cancer Gen and Cytogen"},{"key":"10.1053\/ctrv.2001.0233_RF5","first-page":"1017","article-title":"Germline mutation of the PTEN gene in a Japanese patient with Cowden's disease","volume":"18","author":"Kato","year":"2001","journal-title":"Intern J Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jmg.38.3.159","article-title":"Male breast cancer in Cowden syndrome patients with germline PTEN mutations","volume":"38","author":"Fackenthal","year":"2001","journal-title":"J Med Genet"},{"key":"10.1053\/ctrv.2001.0233_RF7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1520-6823(1999)7:2<55::AID-ROI1>3.0.CO;2-#","article-title":"Tumor suppressor genes and breast cancer","volume":"7","author":"Buchholz","year":"1999","journal-title":"Radiat Oncol Invest"},{"key":"10.1053\/ctrv.2001.0233_RF8","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA-1 mutation carriers","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1053\/ctrv.2001.0233_RF9","unstructured":"Breast Cancer Information Core (BIC) Database on the World Wide Web AT, http:www.nhgri.nih.gov\/intramural research\/lab transfer\/bic"},{"key":"10.1053\/ctrv.2001.0233_RF10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P","article-title":"Frequency of BRCA1-BRCA2 mutations in a population-based sample of young breast carcinoma cases","volume":"88","author":"Malone","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","article-title":"Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer","volume":"91","author":"Peto","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ctrv.2001.0233_RF12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jama.279.12.922","article-title":"BRCA1 mutations and breast cancer in the general population: analysis in women before age 35 years and in women before age 45 years with first-degree family history","volume":"279","author":"Malone","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/ctrv.2001.0233_RF13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1054\/bjoc.2000.1239","article-title":"Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer","volume":"83","author":"Verhoog","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA-1 and BRCA-2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1053\/ctrv.2001.0233_RF15","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1001\/jama.1992.03490140104043","article-title":"Age at onset for familial epithelial ovarian cancer","volume":"268","author":"Amos","year":"1992","journal-title":"JAMA"},{"key":"10.1053\/ctrv.2001.0233_RF16","first-page":"107S","article-title":"Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers","volume":"18","author":"Phillips","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF17","first-page":"119S","article-title":"Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients","volume":"18","author":"Verhoog","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF18","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","article-title":"Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study","volume":"356","author":"Narod","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(19820715)50:2<360::AID-CNCR2820500233>3.0.CO;2-4","article-title":"Natural history of hereditary cancer of the breast and colon","volume":"50","author":"Albano","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF20","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","article-title":"BRCA-associated breast cancer in young women","volume":"16","author":"Robson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF21","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.1999.17.11.3396","article-title":"Survival in hereditary breast cancer associated with germline mutations of BRCA2","volume":"11","author":"Verhoog","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF22","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","article-title":"Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk","volume":"16","author":"Frank","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W","article-title":"Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage","volume":"77","author":"Marcus","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF24","first-page":"471","article-title":"Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer","volume":"56","author":"Eisinger","year":"1996","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2001.0233_RF25","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(95)91060-3","article-title":"Histoprognostic grade in BRCA1-associated breast cancer","volume":"345","author":"Jacquemier","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/bjc.1997.103","article-title":"Histopathology of breast cancer in relation to age","volume":"75","author":"Fisher","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF27","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1101\/gad.11.10.1226","article-title":"Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1\/Brca2, BRCA1\/p53, and Brca2\/p53 nullizygous embryos","volume":"11","author":"Ludwig","year":"1997","journal-title":"Genes Dev"},{"key":"10.1053\/ctrv.2001.0233_RF28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0959-8049(97)89007-7","article-title":"Tumour biological features of BRCA1-induced breast and ovarian cancer","volume":"33","author":"Johannsson","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF29","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","article-title":"The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study","volume":"83","author":"Armes","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF30","first-page":"2011","article-title":"Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers. a population-based study","volume":"59","author":"Armes","year":"1999","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2001.0233_RF31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0046-8177(98)90427-0","article-title":"Pathobiologic characteristics of hereditary breast cancer","volume":"29","author":"Lynch","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1053\/ctrv.2001.0233_RF32","first-page":"1588","article-title":"Mutations at BRCA1: the medullary breast carcinoma revisited","volume":"58","author":"Eisenger","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2001.0233_RF33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<263::AID-IJC11>3.0.CO;2-G","article-title":"Novel indications for BRCA1 screening using individual clinical and morphological features","volume":"84","author":"Eisenger","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF34","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.onc.1202106","article-title":"p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1-and BRCA2-associated breast tumors","volume":"17","author":"Crook","year":"1998","journal-title":"Oncogene"},{"key":"10.1053\/ctrv.2001.0233_RF35","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2200::AID-CNCR14>3.0.CO;2-S","article-title":"Clinicopathologic analysis of BRCA1- or BRCA2- associated hereditary breast carcinoma in Japanese women","volume":"85","author":"Noguchi","year":"1999","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jnci\/91.5.469","article-title":"Frequency of p53 mutations in breast carcinomas of Ashkenazi Jewish BRCA1 mutation carriers","volume":"91","author":"Phillips","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ctrv.2001.0233_RF37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0959-8049(97)10157-5","article-title":"ErbB2 oncogene in human breast cancer and its clinical significance","volume":"34","author":"R\u00e9villion","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF38","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1200\/JCO.2001.19.10.2722","article-title":"Clinical activity of Trastuzumab and Vinorelbine in women with HER2-overexpressing metastatic breast cancer","volume":"19","author":"Burstein","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1053\/ctrv.2001.0233_RF40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W","article-title":"Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes","volume":"83","author":"Loman","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1005853022804","article-title":"Inherited BRCA2 mutation associated with high grade breast cancer","volume":"47","author":"Agnarsson","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/ctrv.2001.0233_RF42","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","article-title":"Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies","volume":"88","author":"Salazar","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ctrv.2001.0233_RF43","first-page":"63","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"The Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00006254-197211000-00001","article-title":"Factors in the causation and incidence of ovarian cancer","volume":"27","author":"Fathalla","year":"1972","journal-title":"Obstet Gynecol Surv"},{"key":"10.1053\/ctrv.2001.0233_RF45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ijc.2910640608","article-title":"Risk modifiers in carriers of BRCA-1 mutations","volume":"64","author":"Narod","year":"1995","journal-title":"Int J Cancer (Pred Oncol)"},{"key":"10.1053\/ctrv.2001.0233_RF46","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.1995.00430090034005","article-title":"The impact of history on ovarian cancer risk: the Utah population database","volume":"155","author":"Kerber","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1053\/ctrv.2001.0233_RF47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y","article-title":"Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women","volume":"80","author":"Karp","year":"1997","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF48","first-page":"2465","article-title":"Germ-Line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1053\/ctrv.2001.0233_RF49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(05)79248-5","article-title":"Survival in early-onset BRCA1 breast-cancer patients. Institut Curie breast cancer group","volume":"352","author":"Ansquer","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF50","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancer and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Canc Inst"},{"key":"10.1053\/ctrv.2001.0233_RF51","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","article-title":"Survival and tumour characteristics of breast-cancer patients with germline mutation of BRCA1","volume":"351","author":"Verhoog","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF52","first-page":"859","article-title":"BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability","volume":"58","author":"Gretersdttir","year":"1998","journal-title":"Canc Res"},{"key":"10.1053\/ctrv.2001.0233_RF53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jnci\/91.3.259","article-title":"Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers","volume":"91","author":"Lee","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ctrv.2001.0233_RF54","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/bjs.1800811038","article-title":"Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21","volume":"81","author":"Porter","year":"1994","journal-title":"Br J Surg"},{"key":"10.1053\/ctrv.2001.0233_RF55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(98)00023-1","article-title":"Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations","volume":"47","author":"Gaffney","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF56","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/ctrv.2001.0233_RF57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/gyno.1993.1265","article-title":"Familial ovarian cancer","volume":"51","author":"Buller","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF58","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/ctrv.2001.0233_RF59","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1200\/JCO.1999.17.11.3653","article-title":"Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?","volume":"17","author":"Phillips","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF60","first-page":"33","article-title":"Worse survival among breast cancer patients in families carrying the BRCA2 susceptibility gene","volume":"367","author":"Sigurdsson","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/ctrv.2001.0233_RF61","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(05)79091-7","article-title":"Survival of patients with breast cancer and BRCA1 mutations","volume":"351","author":"Foulkes","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF62","first-page":"86a","article-title":"No deleterious effects of radiotherapy in women who are heterozygote for a BRCA-1 or BRCA-2 mutation following breast-conserving therapy","volume":"18","author":"Pierce","year":"1999","journal-title":"Proc ASCO"},{"key":"10.1053\/ctrv.2001.0233_RF63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1006350518190","article-title":"Survival and tumor characteristics of German hereditary breast cancer patients","volume":"59","author":"Hamann","year":"2000","journal-title":"Breast Canc Res Treat"},{"key":"10.1053\/ctrv.2001.0233_RF64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJM200001133420209","article-title":"Genetic prognostic markers for colorectal cancer","volume":"342","author":"Offit","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/ctrv.2001.0233_RF65","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/gast.1996.v110.pm8608876","article-title":"Better survival rates in patients with MLH1-associated hereditary colorectal cancer","volume":"110","author":"Sankila","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/ctrv.2001.0233_RF66","first-page":"1","article-title":"Detection of eight BRCA1 mutations in 10 breast\/ovarian cancer families, including 1 family with male breast cancer","volume":"57","author":"Struewing","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1053\/ctrv.2001.0233_RF67","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA-1 mutation carriers","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF68","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF69","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/ctrv.2001.0233_RF70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nature Genetics"},{"key":"10.1053\/ctrv.2001.0233_RF71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jnci\/90.10.761","article-title":"Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes","volume":"90","author":"Brunet","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ctrv.2001.0233_RF72","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1053\/ctrv.2001.0233_RF73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jnci\/87.2.146","article-title":"Can Fenretinide protect women against ovarian cancer?","volume":"87","author":"De Palo","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ctrv.2001.0233_RF74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families","volume":"11","author":"Tobacman","year":"1982","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF75","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/0959-8049(94)00395-L","article-title":"Genetic counselling in the cancer family clinic","volume":"30A","author":"Murday","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/23771003.1996.12314829","article-title":"Genetic counselling for familial cancer risk","volume":"31","author":"Weitzel","year":"1996","journal-title":"Hospital Practice"},{"key":"10.1053\/ctrv.2001.0233_RF77","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1200\/JCO.2001.19.9.2555","article-title":"BRCA1\/2 Testing: complex themes in result interpretation","volume":"19","author":"Peshkin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF78","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II BRCA1 and BRCA2","volume":"277","author":"Burke","year":"1997","journal-title":"JAMA"},{"key":"10.1053\/ctrv.2001.0233_RF79","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/1097-0142(19951115)76:10+<2011::AID-CNCR2820761318>3.0.CO;2-L","article-title":"Ovarian cancer screening: the role of ultrasound in early detection","volume":"76","author":"Karlan","year":"1995","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2001.0233_RF80","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/jnci\/85.21.1748","article-title":"Elevation of multiple serum markers in patients with stage I ovarian cancer","volume":"85","author":"Woolas","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ctrv.2001.0233_RF81","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(00)04501-3","article-title":"Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR","volume":"357","author":"Evron","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2001.0233_RF82","first-page":"S2","article-title":"Detection of premalignant and malignant breast cells by ductal lavage","volume":"97","author":"Dooley","year":"2001","journal-title":"Obst Gyn"},{"key":"10.1053\/ctrv.2001.0233_RF83","first-page":"539","article-title":"False-positive results in dynamic MR mammography","volume":"2","author":"Kaiser","year":"1994","journal-title":"MRI Clinics of North America"},{"key":"10.1053\/ctrv.2001.0233_RF84","first-page":"715","article-title":"MR imaging: its current and potential utility in the diagnosis and management of breast cancer","volume":"8","author":"Kumar","year":"2000","journal-title":"MRI Clinics of North America"},{"key":"10.1053\/ctrv.2001.0233_RF85","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.2001.19.6.1865","article-title":"for the American society of clinical oncology tumor markers expert panel. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American society of clinical oncology","volume":"19","author":"Bast","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2001.0233_RF86","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737201902336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737201902336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T22:17:25Z","timestamp":1704320245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737201902336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0305737201902336"],"URL":"https:\/\/doi.org\/10.1053\/ctrv.2001.0233","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}